We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+13.66%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$14.8B
AUM Growth
+$2.81B
Cap. Flow
+$1.65B
Cap. Flow %
11.18%
Top 10 Hldgs %
32.19%
Holding
1,185
New
65
Increased
729
Reduced
346
Closed
45

Sector Composition

Rank Sector Weight
1 Technology 42.08%
2 Financials 11.46%
3 Healthcare 8.37%
4 Energy 5.47%
5 Consumer Discretionary 4.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CFR icon
351
Cullen/Frost Bankers
CFR
$10.6B
$5.74M 0.04%
54,472
+39,331
+260% +$4.9M
WAL icon
352
Western Alliance Bancorporation
WAL
$9.32B
$5.73M 0.04%
161,116
+127,001
+372% +$7.78M
MELI icon
353
Mercado Libre
MELI
$94.7B
$5.72M 0.04%
4,338
-936
-18% -$1.06M
CDW icon
354
CDW
CDW
$19.2B
$5.7M 0.04%
29,271
+7,147
+32% +$1.4M
PFG icon
355
Principal Financial Group
PFG
$24.6B
$5.7M 0.04%
76,683
-10,955
-13% -$929K
SIRI icon
356
SiriusXM
SIRI
$10.3B
$5.68M 0.04%
143,136
+68,485
+92% +$3.28M
LCID icon
357
Lucid Motors
LCID
$3.02B
$5.67M 0.04%
70,583
+5,542
+9% +$492K
MNKD icon
358
MannKind Corp
MNKD
$1.22B
$5.67M 0.04%
1,382,870
+100,673
+8% +$486K
GFS icon
359
GlobalFoundries
GFS
$29.1B
$5.66M 0.04%
78,396
+4,279
+6% +$270K
BBIO icon
360
BridgeBio Pharma
BBIO
$16.1B
$5.66M 0.04%
341,280
-377,989
-53% -$4.41M
SWTX
361
DELISTED
SpringWorks Therapeutics
SWTX
$5.63M 0.04%
218,829
-99,596
-31% -$2.91M
WBS icon
362
Webster Financial
WBS
$12.7B
$5.6M 0.04%
141,966
+98,059
+223% +$4.71M
IT icon
363
Gartner
IT
$12.3B
$5.57M 0.04%
17,094
+4,132
+32% +$1.37M
SO icon
364
Southern Company
SO
$107B
$5.56M 0.04%
79,956
+8,914
+13% +$600K
AZN icon
365
AstraZeneca
AZN
$242B
$5.51M 0.04%
39,706
+6,961
+21% +$937K
DUK icon
366
Duke Energy
DUK
$96.9B
$5.45M 0.04%
56,535
+6,314
+13% +$624K
BLUE
367
DELISTED
bluebird bio
BLUE
$5.43M 0.04%
85,422
+27,264
+47% +$3.11M
HUM icon
368
Humana
HUM
$43.8B
$5.43M 0.04%
11,175
+299
+3% +$148K
APD icon
369
Air Products & Chemicals
APD
$65.8B
$5.39M 0.04%
18,750
+1,999
+12% +$583K
FDS icon
370
Factset
FDS
$9.7B
$5.35M 0.04%
12,895
-1,810
-12% -$754K
DVAX
371
DELISTED
Dynavax Technologies
DVAX
$5.31M 0.04%
541,039
-105,848
-16% -$1.13M
SNV
372
DELISTED
Synovus
SNV
$5.31M 0.04%
172,141
+120,705
+235% +$4.6M
IMGN
373
DELISTED
Immunogen Inc
IMGN
$5.25M 0.04%
1,367,970
-243
-0% -$1.04K
CLDX icon
374
Celldex Therapeutics
CLDX
$3.05B
$5.24M 0.04%
145,736
+2,405
+2% +$104K
CPAY icon
375
Corpay
CPAY
$25.9B
$5.24M 0.04%
24,851
+12,651
+104% +$2.57M

Similar funds

Rafferty Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, Rafferty Asset Management held 1,185 positions worth $14.8B, up 24% from $11.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Rafferty Asset Management deployed $1.65B of net new capital in Q1 2023, opening 65 new positions and adding to 729 existing holdings. Its largest new stake was Flagstar Bank National Association: 362,459 shares worth $9.83M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $45M trimmed.

  • Rafferty Asset Management's largest Q1 2023 buy was Flagstar Bank National Association: 362,459 shares worth $9.83M.
  • Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q1 2023, an estimated $323M increase.
  • Rafferty Asset Management's biggest Q1 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $45M.
  • Rafferty Asset Management fully exited SVB Financial Group in Q1 2023, selling an estimated $7.88M.
  • Rafferty Asset Management's ten largest holdings make up 32% of its $14.8B portfolio in Q1 2023.
  • Rafferty Asset Management opened 65 new positions and closed 45 in Q1 2023.
  • Rafferty Asset Management's portfolio value rose 24% quarter-over-quarter to $14.8B.

Based on Rafferty Asset Management's 13F filing for Q1 2023, filed 11 May 2023.